Simplify Logo

Full-Time

Senior Research Scientist

Biophysical Characterization and Developability Assessment

Confirmed live in the last 24 hours

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Data & Analytics
Hardware
AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$110k - $137.6kAnnually

+ Equity + Annual Bonus + RRSP Contribution + Active Lifestyle Allowance

Senior, Expert

Vancouver, BC, Canada

Category
Lab & Research
Life Sciences
Required Skills
Data Science
Requirements
  • You have a PhD in Biophysics, Biochemistry, or Structural Biology plus 5-8 years of experience in an industry setting; if you have a MSc and 8-10 years of relevant experience in an industry setting, you will also be considered
  • You have demonstrated expertise in the evaluation of protein interactions and mechanism of action using SPR, BLI, ITC, ELISA, Kinexa, AUC, or related technologies
  • You have experience applying analytical SEC, HIC, IEX, light scattering, CE-SDS, cIEF, DSF, DSC, mass spectrometry, or related techniques to assess sample quality and developability of biotherapeutics
  • You have an in-depth understanding of antibody sequences and structure, as well as common modifications and physical and chemical stability risks
  • You have experience managing and interacting with electronic lab notebook environments, and laboratory information and inventory management systems
  • You have a passion for science, technology, and innovation
  • You have strong interpersonal skills with the ability to work collaboratively as a member of a cross-functional team
  • You have excellent decision-making and troubleshooting skills, as well as effective documentation and organizational skills with a high attention to detail
  • Supporting preclinical development of biologics, particularly bi-/multispecific antibodies, and helping to generate data that supported their clinical development is not new to you
  • You are comfortable writing formal reports with interpretations based on data you generated in complex biological systems to build mechanistic confidence in a target
  • You are self-motivated, and have the initiative to meet project goals under tight timelines
Responsibilities
  • Providing leadership in the application of biophysical characterization methods to assess the binding interactions and developability of biotherapeutics
  • Establishing strategy, developing workflows, and integrating new technologies to assess antibody binding properties including kinetics, affinity, epitope, and mechanism of action, to identify promising therapeutic candidates
  • Designing and executing detailed early formulation and stability studies to identify developable lead molecules
  • Analyzing and interpreting complex data sets including analytical, biophysical, binding, and in silico assessments, to nominate lead candidate antibody molecules to progress into clinical development
  • Providing protein science and biotherapeutic leadership within multidisciplinary drug discovery program teams
  • Mentoring junior scientists within a rapidly growing and dynamic team
  • Collaborating with teammates to leverage automation, data science, bioinformatics and machine learning to expand the throughput of antibody screening, including data curation, analysis and interpretation of large data sets
  • Acting as a subject matter expert for antibody developability and biophysical characterization

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

Series A

Total Funding

$393.1M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

2%

1 year growth

0%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaborations with firms like Viking Global Investors and Biogen expand AbCellera's capabilities and market opportunities.
  • AbCellera's participation in high-profile industry conferences and presentations, such as AACR, showcases its cutting-edge research and strengthens its industry reputation.
  • The company's internal pipeline of therapeutic programs offers potential for significant breakthroughs and new treatments.

What critics are saying

  • The highly competitive and rapidly evolving biopharmaceutical market requires continuous innovation to maintain a competitive edge.
  • The recent resignation of board member Peter Thiel could lead to strategic and governance challenges.

What makes AbCellera Biologics unique

  • AbCellera's proprietary technology platform accelerates antibody discovery, making it faster and more efficient than traditional methods.
  • The company's ability to tackle challenging targets that have been difficult to address with traditional methods sets it apart in the biopharmaceutical market.
  • AbCellera's collaborative business model, which includes partnerships with leading investment firms and biotech companies, enhances its innovation and market reach.